Table of Contents
ISRN Oncology
Volume 2012, Article ID 687298, 6 pages
http://dx.doi.org/10.5402/2012/687298
Research Article

Comparing Lung Cancer Risks in Sweden, USA, and Japan

1Hallberg Independent Research, Brattforsgatan 3, 123 50 Farsta, Sweden
2The Experimental Dermatology Unit, Department of Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden

Received 16 September 2011; Accepted 3 November 2011

Academic Editors: I. Belyaev and A. Lisi

Copyright © 2012 Örjan Hallberg and Olle Johansson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lidman, Kunskapens bok, term “Tobak”; Bokförlaget Natur och Kultur: Stockholm, Sweden, 1955.
  2. J. Kaldor and N. Day, “Mathematical models in cancer epidemiology,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. Fraumeni, Eds., pp. 127–137, Oxford University Press, New York, NJ, USA, 1996. View at Google Scholar
  3. K. Wakai, M. Ando, K. Ozasa et al., “Updated information on risk factors for lung cancer: findings from the JACC study,” Journal of Epidemiology, vol. 15, supplement 2, pp. S134–S139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Ö. Hallberg, “A reduced repair efficiency can explain increasing melanoma rates,” European Journal of Cancer Prevention, vol. 17, no. 2, pp. 147–152, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Persson, I. Sjöberg, and S.-E. Johansson, Healthrelated Habits of life 1980–2002, Statistics Sweden, Örebro, Sweden, 2004.
  6. M. J. Thun, S. J. Henley, and E. E. Calle, “Tobacco use and cancer: an epidemiologic perspective for geneticists,” Oncogene, vol. 21, no. 48, pp. 7307–7325, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. “Viewing the news from abroad,” Japanese Journal of Clinical Oncology, vol. 28, no. 12, pp. 775–777, 2005. View at Publisher · View at Google Scholar
  8. R. Doll, R. Peto, J. Boreham, and I. Sutherland, “Mortality in relation to smoking: 50 years' observations on male British doctors,” British Medical Journal, vol. 328, no. 7455, pp. 1519–1528, 2004. View at Google Scholar · View at Scopus
  9. International Agency for Research on Cancer, http://www-dep.iarc.fr.
  10. WHO, “Tobacco Free Initiative, Economics and Statistics,” http://www.who.int/tobacco/economics/en.
  11. C. Osmond, “Using age, period and cohort models to estimate future mortality rates,” International Journal of Epidemiology, vol. 14, no. 1, pp. 124–129, 1985. View at Google Scholar · View at Scopus
  12. B. Møller, H. Fekjær, T. Hakulinen et al., “Prediction of cancer incidence in the Nordic countries up to the year 2020,” European Journal of Cancer Prevention, vol. 11, no. 1, pp. S1–S96, 2002. View at Google Scholar · View at Scopus
  13. W. D. Flanders, C. A. Lally, B. P. Zhu, S. J. Henley, and M. J. Thun, “Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from cancer prevention study II,” Cancer Research, vol. 63, no. 19, pp. 6556–6562, 2003. View at Google Scholar · View at Scopus
  14. A. J. Sasco, M. B. Secretan, and K. Straif, “Tobacco smoking and cancer: a brief review of recent epidemiological evidence,” Lung Cancer, vol. 45, supplement 2, pp. S3–S9, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. G. Arbeev, S. V. Ukraintseva, L. S. Arbeeva, and A. I. Yashin, “Mathematical models for human cancer incidence rates,” Demographic Research, vol. 12, pp. 237–272, 2005. View at Google Scholar · View at Scopus
  16. S. V. Ukraintseva and A. I. Yashin, “Economic progress as cancer risk factor. II. Why is overall cancer risk higher in more developed countries?” MPIDR Working Paper WP 2005-022, Max Planck Institute for Demographics Research, Rostock, Germany, 2005. View at Google Scholar
  17. Q. Wei, L. Cheng, W. K. Hong, and M. R. Spitz, “Reduced DNA repair capacity in lung cancer patients,” Cancer Research, vol. 56, no. 18, pp. 4103–4107, 1996. View at Google Scholar · View at Scopus
  18. L. Cheng, M. R. Spitz, W. K. Hong, and Q. Wei, “Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis,” Carcinogenesis, vol. 21, no. 8, pp. 1527–1530, 2000. View at Google Scholar · View at Scopus
  19. R. A. El-Zein, C. M. Monroy, A. Cortes, M. R. Spitz, A. Greisinger, and C. J. Etzel, “Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers,” BMC Cancer, vol. 10, p. 439, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. D. R. Gandara, T. Kawaguchi, J. Crowley et al., “Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics,” Journal of Clinical Oncology, vol. 27, no. 21, pp. 3540–3546, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus